In screening drugs, determination of it toxicity is usually part of the initial step in their assessment and evaluation, phytochemical constituents and their isolation can subsequently be determine. Sclerocya birrea is a plant employed ethno medicinally in the treatment of different parasitic infection such as malaria. This study examine the anti-malarial and antibacterial activity of plant leaf extracts against Plasmodium berghei using Swiss albino mice invivo and Salmonella typhi isolates. Also acute toxicity (LD 50 as the index), phytochemical screening and FTIR characterization of the aqueous and ethanolic leaf extracts of the plant were conducted. The LD 50 was based on Lorke's method using mice, while phytochemical screening and FTIR characterization based on the routine procedures. The results indicated that LD 50 of the aqueous and ethanolic extracts were 566 and 800 mg/kg body weight, (intra-peritoneal), respectively. The phytochemical screening revealed the presence of alkaloids, Anthraquinones in the Free State, Carbohydrate (Reducing sugar) and Flavonoids. Also present include Phlobatanins, saponins, tannins and terpenoids all of which are detected in both extracts. However, Cardiac Glycoside and steroids are only detected in the aqueous extract. FTIR spectroscopy indicted the presence of functional groups such as C-H,C = O and O-H, indicating the peaks for alkanes, alcohols, aromatics and Carboxylic acid, While C-O-C,C-C(O)-C, C-N, C-I, N-H indicated the peak for ether, ester, Amine, amide, aldehyde and (alkyl halide). P = O (Phosphine oxide) and C = C (conjugate) (Alkene) also indicated in the extracts. Ethanolic extract is characterize with certain peculiar functional groups such as C-C(O)-C, C-O-C, C-H bend and C-H stretch relating to ethers, esters, aromatics and aldehyde/ketones. The mice were grouped according to their weights and the extracts administered curatively against Plasmodium berghei based on standard procedures. The research finding shows that both aqueous and ethanolic leaf extracts of Sclerocarya birrea was 100% effective against Plasmodium berghei. Double dilution method was used to determine the antibacterial activity of the identified S. birrea in vitro. The aqueous and ethanol extract of Sclerocarya birrea showed an MIC of 3×10 -4 mg/mL and 4×10 -4 mg/mL, respectively; while both extracts were found to have the same MBC of 4×10 -4 mg/mL. The values of their MIC and MBC prove promising in further antibacterial research breakthrough.
INTRODUCTION
Sclerocarya birrea (A. Rich.) Hochst. is a common species throughout the semi-arid savannas of sub-Saharan Africa. It is commonly known as marula (English), Danyaa (Hausa) Jinjere goyi (Nupe), the family Anacardiaceae which encompasses 73 genera and 352,600 species (Van Wyk et al., 1997) , locally known as marula. It is widespread in Africa from Ethiopia in the north to KwaZulu-Natal in the south. In South Africa it is more dominant in the Baphalaborwa area in the Limpopo province. It occurs naturally in various types of woodland, on sandy soil or occasionally on sandy loam (MacGaw et al., 2007) . It has multiple uses, including the fruits that are eaten fresh and sucking the juice or chewing the mucilaginous flesh after removal of the skin. The ripe fruit has an average vitamin C content of 168 mg/100 g which is approximately three times that of oranges and comparable to the amounts present in guavas (Wilson, 1980; Christensen and Kharazmi, 2001) . The kernels are eaten and cooking oil can be extracted from them. The leaves are browsed by livestock and have medicinal uses (Muok et al., 2009) as does the bark. Several researchers have reported biological activities of S. birrea extracts, but no comprehensive anti-Plasmodia activities of the plant have been reported, although it is widely used by traditional healers. (Eloff, 2001) reported antibacterial activity of acetone extracts of S. birrea against Staphylococcus aureus, Pseudomonas aeruginosa, Enterococcus faecalis and Escherichia coli. (MacGaw et al., 2007) have also reported its antibacterial, antihelmintic and cytotoxic effects. Anticonvulsant effect of S. birrea stem-bark aqueous extract in mice was reported by Ojewole and Adewole (2007) and Runyoro et al. (2006) have investigated 34 medicinal plants used by Tanzanian traditional healers in the management of Candida infections and they reported that the ethanolic extract of dried stem bark of S. birrea showed antifungal activity against C. albicans.
Herbal prescriptions and natural remedies are commonly employed in developing countries for the treatment of various diseases; this practice is employed as an alternative way to compensate for some perceived deficiencies in orthodox pharmacotherapy (Sofowora, 1995; Zhu et al., 2002) . Unfortunately, there is limited scientific evidence regarding safety and efficacy to back up the continued therapeutic application of these remedies. More so, there is limited scientific evidence regarding the anti-malaria and anti-typhoid efficacy to back up its continued therapeutic application. The rationale for plant utilization has rested largely on longterm clinical experience (Zhu et al., 2002) . However, with the upsurge in the use of herbal medicines, a thorough scientific investigation of these plants will go a long way in validating their folkloric usage (Sofowora, 1993) . This study is therefore designed to investigate the anti-malarial and anti typhoid activity of the aqueous and ethanolic extracts of S. birrea and to further assess the acute toxicity using LD 50 as the index to detect the phytochemicals and carried out the FTIR characterization of the aqueous and ethanolic leaf extracts of the plant.
MATERIALS AND METHODS

Plant materials:
Fresh leaves of Sclerocarya birrea plant were collected from Zaria road and Maguzawa Rigasa, Kaduna between March and April. The sampled leaf was duly authenticated at applied science department, Kaduna Polytechnic, Kaduna. The leaves were collected and washed thoroughly with water and air dried in a shady area at room temperature (25°C) for about two weeks. The dried leaves were pulverized using pestle and mortar. The processed leaves were then stored in a brown bottles away from sunlight until required.
Extraction: 100 g of the plant sample was weighed on a watch glass and transferred into a porous thimble which was place in soxhlet extractor. The plant extract was extracted with 500 mL of ethanol. While the aqueous extract was obtained by maceration sequentially using the dried residue of the leaf of S. birrea obtained from the ethanol extraction. 100 g powdered of the leaf was macerated in 500 mL of distilled water for 48 h with an occasional shaking. It was then filtered by the use of cheese cloth, after which it was properly suction filtered and concentrated by the use of water bath at 60°C (Sofowora, 1995) . The extracts were collected in a flask with air tight cover and kept for further tests. The percentage yield of oil was calculated as follows:
Percentage yield = weight of n−hexane extract obtained Total Weight of Sample
× 100
Acute toxicity test: Acute toxicity studies: The LD 50 was carried out by adopting the method outlined by Lorke (1983) with a little adjustment. A total 26 Swiss albino mice (Musmusculus) were used for the study of the two extracts. In the initial phase, nine mice were grouped into three groups of three mice each and they were treated with extract at doses of 10,100 and 1000 mg/kg body weight intra-peritoneally and observed for 24 h. In the second phase which is deduced from the first phase, four mice were grouped into four groups of one mouse each and they were treated with doses of 400, 800 1600 and 3200 mg/kg body weight intra-peritoneally. They were also observed for 24 h as in the first phase and final LD 50 value was determined (Lorke, 1983) .
Phytochemical screening: All extracts obtained were screened for phytochemical constituents which include Alkaloids, Anthraquinones, Carbonhydrate (Reducing sugar), Cardiac Glycoside, Flavonoids, Phlobatanins, Saponins, Steroids and Tannins using standard quantitative procedures (Harbone, 1973; Trease and Evans, 1989; Sofowora, 1993) .
Characterization procedure: The routine procedure for the infrared analysis by Egwaikhide and Gimba (2007) was adapted, with little modification, using Fourier Transformed Infrared (FTIR) spectrophotometer model 8400s. The extracts were scanned in accordance with ASTM 1252-98. A drop of each extract was applied on a sodium crystal disc using a special mould and a hydraulic press to obtain a thin layer. The cell was mounted on the FT IR and scanned through the IR region.
In-vivo test:
Parasite inoculation: The Plasmodium berghei was obtained from National Pharmaceutical Research Institute Abuja through the Department of Biochemistry, Federal University of Technology, Minna and maintained by blood transfer in albino Swiss mice of body weight (21-24 g) of the same sex.
The Plasmodium berghei was prepared and inoculated as described by Okonkon et al. (2008) . The blood was prepared by determining the percentage parasitemia and the erythrocytes count of the donor mouse and further diluting the blood with normal saline in proportion such that 0.2 cm 3 of the blood contains 1.0×10 7 P. berghei parasitized erythrocytes. 0.2 cm 3 of the infected blood was inoculated intra-peritoneally to each mouse on day 0.
Animal grouping: Albino Swiss mice of weight 21-24 g of the same sex were obtained from Animal house of Ahmadu Bello University Zaria. They were maintained on standard animal pellets and enough water. The animals were grouped into four groups of 3 mice each identified as group A, B, C and D.
Curative schizontal activity of the extract:
The evaluation of anti-plasmodia activity of the extracts was carried out using the curative method described by Ryley and Peters (1970) with the following modification. Each mouse was inoculated on the first day (0) intra-peritoneal with 0.2 cm 3 of infected blood containing about 1.0×10 7 P. berghei parasitized RBCs. Seventy two hours later Group A animals were administered Chloroquine orally at 10 mg/kg/day. Equivalent volume of distilled water (Negative control) was given to Group B animals. Group C and D were orally administered with aqueous and ethanolic extracts respectively using concentrations of extracts 40 mg/kg/day. The drug and the extracts were given once daily for 5 days. The parasitemia level was monitored using a prepared thin film and Giemsa stained obtained from the mice tail daily for 5 days. The mean survival time for each group was determine by arithmetic means (Average survival time/day) of the mice after inoculation in each group over a period of 15 days (day 0 to day 14) as described by Okonkon et al. (2008) . From the thin films made from the tail blood of each mouse, parasitaemia level was determined by counting the number of parasitized RBCs out of 200 erythrocytes in random fields of the microscopes. Average percentages (%) were then calculated.
Physical parameters such as body temperature, heartbeat rate and body weight of the animals were examined, before and after treatments.
Bacterial isolates and bioassays:
Source of bacterial isolates: The bacterial isolated used was Salmonella typhi which was clinical isolated from Yusuf Dantsoho Memorial Hospital Microbiology Laboratory. The bacterial isolates were then gramstained, after which this biochemical tests (which include the Lysine decarboxylase reaction) was carried out.
Biochemical test to identify Salmonella typhi:
The Kligler Iron Agar (KIA) and Rosco Enzyme tests (based on Lysine decarboxylase and KIA) are used to identify Salmonella typhi (Cheesbrough, 2005) . The gram-stained growth was emulsified with a small amount of KIA in a loop full of physiological saline on a slide. It was then mixed by tilting the slide backwards for about 30 sec. It was then examined for agglutinations against a dark background. There was no agglutination observed. One loop full of test anti-serum was then added and mixed. It was then re-examined for agglutination. The presence of a story clear agglutination within one minute confirms that the strain in Salmonella typhi.
Anti-microbial activity of the extract:
The antimicrobial activity of the extracts was done by the Determination of Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) as adopted by Dewanjee et al. (2007) with some modification.
MIC was determined by tube dilution method for the test organism in triplicates (Doughari et al., 2007) . To 2 mL of varying concentrations of the extracts (range of 10-50 μg/mL for both aqueous and ethanol extracts), 2 mL of nutrient broth was added and then a loopful of the overnight test organism previously diluted to 0.5 McFarland turbidity standard (Cheesbrough, 1999) , was introduced to the tubes. The procedures were repeated on the test organisms using standard antibiotics Ampicillin. A tube containing nutrient broth only seeded with the test organism served as control. Tubes containing bacterial cultures were then incubated at 37°C for 24 h. After incubation the tubes were examined for microbial growth by observing the turbidity.
To determine the MBC for the set of test tubes in the MIC determination, a loop full of broth was collected from those tubes which did not show any growth and inoculated on sterile nutrient agar by streaking. Plates inoculated are then incubated at 37°C for 24 h. After incubation the concentration at which no visible growth was seen was noted as MBC.
RESULTS
Percentage yield:
The ethanolic extract of Sclerocarya birrea has higher percentage yield with 13.336% while aqueous has 12.86% (Table 1) .
(LD 50 for aqueous extracts is given by the square root the two values):
LD 50 (aqueous) = √400 × 800 2 = √320000 = 566 mg/kg (i.p) (Lorke, 1983 )) The LD 50 of the aqueous and ethanol extracts of S. birrea were found to be 566 and 800 mg per kg body weight, (intra-peritoneal) respectively ( Table 2) .
The animals after 24 h of the administration of the extracts of S. birrea show weight loss, increased body temperature and heartbeat and a slight decrease in food consumption ( Fig. 1 and 2) .
The animals after 24 h period, after the administration of the extracts of S. birrea show weight loss, increased body temperature and heartbeat and a slight decrease in food consumption ( Fig. 1 and 2) .
The average increase in body temperature and heartbeat was comparatively high (Fig. 2 to 4) and some mice in the phase II died as a result, which cannot be unconnected to the increased concentration of the extracts. FTIR characterization: FTIR spectroscopy as shown in Table 3 (Table 4) .
Variation in the physical parameters: Table 5 showed that mice in all the groups showed variations in the average rate of heart beat, body temperature and the body weight before and after treatment. A general increase in the body temperature in all the groups between 32°C and 35°C is observed, which can be considered as possible indication of manifestation of Plasmodium species. That was followed by subsequent fall in the temperature between 30 to 31°C of the treated groups. The temperature of the control group increases progressively from 35 to 43°C (Table 5 ). There was progressive increase in the average heartbeat rate between 60 and 64 pulses per minute after infection, before treatment. However, during and after the treatment a remarkable decrease was observed the heartbeat rate was between 62 and 50 pulses per minute, however the control group remain progressively high up to 67 pulses per minute, which could be an indication of progress in malaria ailment (Table 5 ). There was an average weight loss within 2 of the treated groups (0.8 to 2.8% loss) and control groups (the weight loss is about 8.1%). The effect of which cannot be unconnected to the infection, based on the 
fact that the proportional growth rate within the period retarded and the growth of the animals was maintained within the same range as obtained before and after treatment.
In vivo anti-malarial activity: The group of mice treated with Chloroquine phosphate showed almost total clearance of about 100% at day 6 ( Table 6 ) and showed 100% protection from the parasites after treatment ( Table 7) . The group of mice that were left as control and treated with distilled water group B showed daily progressive increase in the average parasitamea from 3% (day 2) to 19% (day 4) to 34% (day 6) and a total mortality at the end of the experiment. The group C mice treated with aqueous extract also showed daily increase from 3% (day 1) to 8% (day 3) and suddenly reduced to 6.5% (day 4) down to 0% (day 7) and the extract showed 100% protection (Table 7) . In group D mice treated with ethanolic showed daily percentage increase from 4% (day 1) to 9% (day 3) then reduced to 6% (day 4) to 0% (day 7). The extract showed 100% protection at the end of the experiment ( Table 7) .
Identification of S. typhi:
The strains of the isolates were motile and showed a positive test to lysine decarboxylase by the presence of agglutination. This confirms that the isolate is S. typhi.
McFarland turbidity standards:
The concentration of the bacterial cells was found to be 6×10 8 /mL, this is because test tube 2 corresponds to the turbidity of the standard inoculant and hence the cell density, which is equivalent to 6×10 8 /mL.
The MIC of the aqueous and ethanol extracts of S. birrea were found to be 30 µg/mL and 40 µg/mL, respectively and their MBC were found to be 40 µg/mL; while the MIC and MBC of the standard antibiotic (Ampicillin) was found, both to be 10 µg/mL (Table 8) .
DISCUSSION
The results of this investigation showed that ethanolic extract of Sclerocarya birrea have high percentage yield 13.33% yield, while aqueous extract yield 12.86%. This might probably explain why ethanolic extract gives higher number of characteristic functional groups, even though the differences in proportion is small (Table 1) .
The acute toxicity study of the extracts revealed that LD 50 values of aqueous and ethanolic extracts are 566 and 800 mg/kg (i.p.) which are greater than 500 mg/kg body weight. Therefore, the sclerocarya birrea can be categorized as relatively non-toxic based on the scale proposed by Lorke (1983) . This study shows that the ethanolic extract could be safer for oral consumption. However, in higher concentration the animals showed slight loss of appetite and reduction in fluid consumption. The animals within 24 h period after the administration of the extracts of S. birrea showed loss of weight, increased body temperature and heartbeat and a slight decrease in food consumption. Colour of the eyes was darker than those of the control. However, the mice that survived regained full health within 48 h after the study. This is because they show an increased consumption of food, even greater than that of the control and a more steady heartbeat, body weight and body temperature was recorded. There was no much effect on the group of mice in phase I, due to the lower level of concentration of the extracts administered ( Fig. 1 and 2) . Some mice in the phase II died, which can possibly be associated to increased concentration of the extracts (Table 2) . Before their death, they showed some physiological changes such as weakness of the body (sluggishness), dark eye coloration and reluctance to feeding within the first 24 h after administration. In a related development The LD 50 value of 400 mg/kg body weight in mice i.p. signifies the extract to be slightly toxic to the experimental model as stated by Matsumura (1975) who classified the chemical based on their LD 50 values and pointed out that LD 50 of 500-5000 mg/kg as slightly toxic to the experimental model. The increased body temperature and heartbeat and a decrease in food consumption effects of the aqueous extract can reduce the fluid intake in rats and may be responsible for the loss in body weight of the animals ( Fig. 3 and 4) . Such effect might also be attributed to tannin and saponnin which are anti-nutritional factors (Umaru et al., 2007) . Tannins have the ability to precipitate certain proteins and can therefore, combine with digestive enzymes thereby making them unavailable for digestion (Abara, 2003; Binita and Khetapaul, 1997) . The changes in the physciological parameters such as increase in body weights are peculiar to diseased organisms (Sofowora, 1995) . The administration of the extracts of S. birrea at high concentrations above the LD 50 might trigger such effects. The pale coloration of some internal organs of the mice killed by a high dose of extracts may be as a result of some physiological changes of the internal organs caused by the administration of the extracts (Barlow and Goh, 2002) . This however requires a further study to determine the actual cause of death.
This research indicated that phytochemicals identified from Sclerocarya birrea leaf extracts include alkaloids, Anthraquinones in the free state, Carbonhydrate (Reducing sugar), Cardiac Glycoside and Flavonoids. Also present include Phlobatanins, saponins, streroid, stannins and terpenoids (Table 4) (Table 4 ). The presence of phenols, amine, Carboxylic acid, amide, aldehydes/ketones and alcohols which are the principal functional groups of the identify phytochemicals correlated with the findings from the spectral analysis of the extracts. This support the report by Ndhlala et al. (2007) that the pulp of S. birrea possesses phenolics flavanoids and condensed tannins; although he reported was based on the pulp of the plant, the relationship strongly be correlated.
The finding from this study showed that both aqueous and ethanolic extracts of the leaf of Sclerocarya birrea contains anti-Plasmodia substances with properties that showed curative effects on the established malaria parasites infection. Both aqueous and ethanolic extract showed high potential that is compatible to the standard drug, Chloroquine as demonstrated by the mean survival time of the mice after treatment (Table 6 ). The doses of the crude extracts administered (40 mg/kg) and that of the chloroquine was 10 mg/kg body. it therefore implies that if the crude extract can be further purify for the lead compound to be isolated higher potential might speculated.
The parasite clearance capacity demonstrated by the plant from the result could be describe as time dependent. This is based on the fact that initially, there was increase in parasitamea levels in all groups progressively before the commencement of the treatment. On the initiation of treatment there was drastic reduction in the parasite level as recorded (Table  8 ). The identified phytochemicals are directly link to the medicinal activity of the herbs. More so, the constituent compounds identify may act singly or synergistically with one or more phytochemicals to achieve the desire activities as suggested by Kirby et al. (1989) .
The anti-Plasmodial activity of the two extracts could be associated with the presence of Alkaloids (Harborne and Williams, 2001; Heinrich et al., 2004) , terpenoids (Bruneton, 1999; Heinrich et al., 2004) . Although the mechanism of their action is yet to be elucidated, literature had shown that alkaloids such as cryptolepine interact with DNA of the parasite; it appeared that two nitrogen atoms N and N-CH 3 of cryptolepine interact with adenine-thymine base pair. More so the possible formation of π-π charge transfer complex between purine-pyrimidine bases is speculated (Kirby et al., 1989) . Sesquiterpene on the other hand is believed to interfere with the protein synthetic pathway of the parasite. Moreover one of the mechanisms of action is due to its inhibition of cytochrome oxidase, which occurs at the plasma, the nuclear and the food vacuole-limiting membranes as well as in the mitochondria of the trophozoites of P. berghei (Zhao et al., 1986) . Some other plant extracts phytochemicals are said to exhibit their anti-plasmodia activity by causing the oxidation of red blood cells (Etkin, 1997) depending on the phytochemical constituents. However, the constituent compounds identify may act singly or synergistically with one or more phytochemicals to achieve the desire activities as suggested by (Kirby et al., 1989) .
The antibacterial activity of the extracts of S. birrea showed that the MBC and MIC of both extracts inhibited and consequently kill the bacteria S. typhi at an appreciable concentration with the aqueous extract exhibiting higher sensitivity (MIC 30 μg/mL and MBC 40 μg/mL) (Table 8 ) while ethanolic extract (MIC 40 µ/mL MBC 40 μg/mL) (Table 8 ). However both are considered highly sensitive when compare with study of Dewanjee et al. (2007) . The antibacterial activity of the standard antibiotics was found to be higher (MIC and MBC 10 µ/mL), probably because the lead compound is isolated. However, further characterization, identification and isolation of the biologically active component of S. birrea may be useful for the further elucidation, since the mass of the crude extract which contains different components was equal to the mass of the powdered antibiotic, but the concentration of the active components differs. This research work confirm the report of Eloff (2001) who reported antibacterial activity of S. birrea leaves and bark extracts against Gram-positive and G-negative bacteria such as S. aureus, P.aeruginosa, E.coli and E. faecalis with MIC values ranging from 0.15 to 3 mg/mL and further reported that based on minimum inhibitory concentration values, inner bark extracts tended to be the most potent followed by the outer bark and leaf extracts (Masoko et al., 2008) . The sensitivity of the extracts might be attributed to the presence of secondary metabolites such as flavonoids, phenolic groups and steroids as suggested by previous reports (Kosalec et al., 2005; Pereira et al., 2007; Caceres et al., 1993) . Thus our findings revealed the medicinal potential value of the extract of Sclerocarya birrea and the lead compound need to be isolated.
CONCLUSION
The result of the present study showed that Sclerocarya birrea leaf extracts are active against both Plasmodium berghei and Salmonella typhi parasites, respectively. This therefore justifies the traditional usage of this plant as malaria and typhoid remedy. Sclerocarya birrea leaves are therefore a potential source of drug for the effective treatment of malaria and typhoid.
